Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Olaparib + Sapacitabine in BRCA Mutant Breast Cancer [Phase 1]
Phase 1 trial updating the combination of olaparib with sapacitabine in BRCA-mutant breast cancer. The study is currently active but not rec…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)
This completed qualitative study investigates how patients with metastatic breast cancer and their clinicians can improve shared decision-ma…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Weight Management After Cancer for Survivors in Rural Communities [NA]
A Duke University-sponsored clinical trial is evaluating weight management among breast cancer survivors in rural communities. The study is …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study [Phase 2]
A multi-centre Phase II feasibility trial evaluating tucatinib, trastuzumab, and capecitabine with brain/spinal radiotherapy in patients wit…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer [Phase 2]
Phase 2 study to evaluate the safety and tolerability of Camizestrant in combination with Atirmociclib in women with advanced breast cancer.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis [Phase 4]
Phase 4 trial evaluating 64Cu-DOTA-Trastuzumab PET/MRI for imaging HER2-positive breast cancer with brain metastases; currently recruiting a…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Circulating Tumour Cells Characterization in Breast Cancer Patients
A clinical trial in breast cancer is currently recruiting to characterize circulating tumor cells in patients.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy
A breast cancer clinical trial is recruiting to test lymph node identification using magnetic tracers Magtrace and Magseed before chemothera…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring [NA]
Carevive Systems is conducting a real-world study evaluating remote symptom monitoring for patients with breast cancer, lung cancer, gastroi…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: ROLL Versus Magnetic Seed for Preoperative Localization of Non-palpable Breast Lesion: Comparison Between Techniques.
This clinical trial compares radioguided occult lesion localization (ROLL) with magnetic seed localization for preoperative marking of non-p…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: The Active After Cancer Trial (AACT) [NA]
Clinical trial update for the Active After Cancer Trial (AACT). The study is currently active but not recruiting, and it involves breast can…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: IRIS: Risk-Based Imaging After Breast-Conserving Surgery [NA]
This entry reports a clinical trial named IRIS evaluating risk-based imaging after breast-conserving surgery for breast cancer; the study is…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
A clinical trial update describing a real-world study on treatment experiences for breast, lung, ovarian cancer, multiple myeloma, and acute…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer [Phase 2]
Phase 2 trial investigating ctDNA-guided omission of chemotherapy in combination with ribociclib and endocrine therapy for HR-positive/HER2-…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: GammaPod Dose Escalation Radiation for Early Stage Breast Cancer [NA]
This clinical trial is evaluating dose escalation of GammaPod radiation for early-stage breast cancer and is currently recruiting. Sponsored…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents [Phase 1, Phase 2]
Clinical trial update on ascending doses of ceralasertib in combination with chemotherapy or other anti-cancer agents in advanced solid mali…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer) [Phase 3]
A Phase 3 clinical trial update comparing giredestrant plus palbociclib with letrozole plus palbociclib in ER-positive, HER2-negative locall…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Additional Imaging Methods for Assessing Axillary Lymph Node Involvement in Breast Cancer [NA]
The clinical trial evaluating additional imaging methods for assessing axillary lymph node involvement in breast cancer has completed. Spons…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer. [Phase 2]
This update notes a Phase 2 neoadjuvant trial of letrozole for postmenopausal women with HR-positive, HER2-negative, node-positive breast ca…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM) [NA]
A precision oncology diagnostic study (PRISM) in primary and metastatic breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating Efti in patients with hormone receptor-positive, HER2-negative breast cancer; not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers [NA]
Clinical trial evaluating early multigene sequencing for theranostics in advanced cancers to guide therapy, across breast cancer, hepatocell…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: GammaPod Registry and Quality of Life Nomogram
This clinical trial update describes the GammaPod Registry for breast cancer patients and a quality-of-life nomogram being studied. The tria…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer [NA]
Sponsored by Fundacio Clinic Barcelona, the study evaluates diagnostic HER2DX-guided treatment for early-stage HER2-positive breast cancer. …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: STOP-HER2: Stopping Trastuzumab in HER2+ MBC [Phase 2]
Clinical trial update indicating the STOP-HER2 Phase 2 study investigating stopping trastuzumab in HER2-positive metastatic breast cancer.